Novan Therapeutics: Nitric Oxide May Inhibit Skin Steroidogenesis Locally

April 8, 2013

Novan Therapeutics reports topical nitric oxide-based therapies may reduce androgen levels in the skin by locally inhibiting skin steroidogenesis. The targeted reduction of androgens in the skin could lead to first-in-class local antiandrogen products to treat acne and androgenic alopecia (male pattern baldness). The science is detailed in a new report, posted online.

Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free